Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression
Introduction The progression patterns, dispositions, and outcomes of patients with advanced hepatocellular carcinoma (HCC) who achieved durable responses with immunotherapy remain poorly characterized. Methods Patients with advanced HCC who received immune checkpoint inhibitor (ICI)-based immunoth...
| الحاوية / القاعدة: | Liver Cancer |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Karger Publishers
2024-02-01
|
| الوصول للمادة أونلاين: | https://beta.karger.com/Article/FullText/536549 |
